GEMMATI, Donato
 Distribuzione geografica
Continente #
NA - Nord America 23.116
AS - Asia 13.945
EU - Europa 9.773
SA - Sud America 2.279
Continente sconosciuto - Info sul continente non disponibili 459
AF - Africa 320
OC - Oceania 34
Totale 49.926
Nazione #
US - Stati Uniti d'America 22.389
SG - Singapore 5.160
CN - Cina 3.380
IT - Italia 2.735
DE - Germania 1.876
BR - Brasile 1.790
VN - Vietnam 1.549
UA - Ucraina 1.249
HK - Hong Kong 1.174
GB - Regno Unito 862
PL - Polonia 787
TR - Turchia 699
FI - Finlandia 541
BD - Bangladesh 459
FR - Francia 457
CA - Canada 423
JP - Giappone 387
RU - Federazione Russa 334
IN - India 304
SE - Svezia 277
MX - Messico 210
AR - Argentina 180
ID - Indonesia 172
NL - Olanda 128
ZA - Sudafrica 117
IQ - Iraq 101
ES - Italia 82
BE - Belgio 71
PK - Pakistan 70
CO - Colombia 69
EC - Ecuador 67
VE - Venezuela 62
UZ - Uzbekistan 58
CZ - Repubblica Ceca 51
MA - Marocco 51
SA - Arabia Saudita 51
SM - San Marino 49
MY - Malesia 43
EG - Egitto 41
CH - Svizzera 40
AT - Austria 39
LT - Lituania 39
PH - Filippine 38
AE - Emirati Arabi Uniti 36
IR - Iran 36
CL - Cile 34
PY - Paraguay 33
IE - Irlanda 31
AU - Australia 27
KE - Kenya 26
NP - Nepal 26
TN - Tunisia 24
UY - Uruguay 21
RO - Romania 20
JM - Giamaica 19
AZ - Azerbaigian 17
IL - Israele 17
JO - Giordania 17
CR - Costa Rica 16
TH - Thailandia 15
GR - Grecia 14
KZ - Kazakistan 14
LK - Sri Lanka 13
PE - Perù 13
PT - Portogallo 13
TW - Taiwan 13
DZ - Algeria 12
KR - Corea 12
LB - Libano 12
PS - Palestinian Territory 12
SN - Senegal 12
DO - Repubblica Dominicana 11
OM - Oman 11
AL - Albania 10
GT - Guatemala 10
BO - Bolivia 9
EU - Europa 9
SK - Slovacchia (Repubblica Slovacca) 9
TT - Trinidad e Tobago 9
BG - Bulgaria 8
DK - Danimarca 8
ET - Etiopia 8
RS - Serbia 8
BY - Bielorussia 7
GE - Georgia 7
HN - Honduras 7
KW - Kuwait 7
QA - Qatar 7
A2 - ???statistics.table.value.countryCode.A2??? 6
HU - Ungheria 6
BH - Bahrain 5
KG - Kirghizistan 5
NZ - Nuova Zelanda 5
GD - Grenada 4
NG - Nigeria 4
NI - Nicaragua 4
NO - Norvegia 4
PA - Panama 4
AO - Angola 3
CG - Congo 3
Totale 49.414
Città #
Singapore 3.029
Ashburn 2.347
Woodbridge 1.674
Fairfield 1.521
San Jose 1.438
Jacksonville 1.364
Chandler 1.325
Hong Kong 1.156
Beijing 1.056
Santa Clara 1.043
Houston 992
Ann Arbor 977
Warsaw 773
Seattle 625
Wilmington 615
Ho Chi Minh City 499
New York 473
Cambridge 445
Izmir 422
Munich 411
Los Angeles 407
Nanjing 390
Dallas 367
Tokyo 365
Hanoi 359
Ferrara 335
Milan 309
Princeton 292
Council Bluffs 280
Lauterbourg 273
Boardman 238
Helsinki 191
São Paulo 159
Rome 153
Orem 147
Mexico City 144
Shanghai 142
San Diego 141
Mcallen 130
Buffalo 128
Montréal 122
Bologna 119
London 118
The Dalles 118
Shenyang 117
Toronto 106
Dearborn 99
Jakarta 98
Nanchang 96
Montreal 93
Changsha 90
Tianjin 90
Da Nang 88
Turku 88
Chicago 86
Hebei 86
Bremen 81
Chennai 80
Denver 77
Brooklyn 74
Jiaxing 74
Hefei 69
Frankfurt am Main 68
Haiphong 68
Rio de Janeiro 68
Brussels 65
Phoenix 63
Johannesburg 61
Boston 56
Naples 55
Jinan 53
Redwood City 53
Atlanta 52
Belo Horizonte 51
Düsseldorf 51
Greven 51
San Francisco 51
Stockholm 50
Tashkent 50
Berlin 49
Bottrop 49
Guangzhou 49
Norwalk 49
Falls Church 48
Baghdad 46
Manchester 43
Moscow 41
Brasília 39
Nuremberg 39
Poplar 38
Dong Ket 37
Falkenstein 37
Mountain View 37
Amsterdam 36
Kunming 35
Zhengzhou 35
San Mateo 33
Verona 32
Des Moines 31
Mumbai 31
Totale 31.004
Nome #
Nanobiomaterials for vascular biology and wound management: a review 1.312
FISIOPATOLOGIA DELL'EMOSTASI E DELLA COAGULAZIONE 733
ProC Global test>ProC Complete test: una modificazione del Global test per la misurazione contemporanea della attività della PC, della PS, e del fenotipo Leiden. 589
Gene-gene interactions among coding genes of iron-homeostasis proteins and APOE-alleles in Cognitive Impairment Diseases 490
Impact of methylenetetrahydrofolate reductase C677T polymorphism on the efficacy of photodynamic therapy in patients with neovascular age-related macular degeneration 371
C6orf10 low-frequency and rare variants in italian multiple sclerosis patients 361
Gene polymorphisms in folate metabolizing enzymes in adult acute lymphoblastic leukemia: effects on methotrexate-related toxicity and survival 292
Inherited genetic predispositions in F13A1 and F13B genes predict abdominal adhesion formation: identification of gender prognostic indicators 291
Fisiopatologia della Coagulazione. 289
Ricerche metodologiche sul dosaggio del cofattore Ristocetinico per la diagnosi di morbo di von Willebrand. 283
Coagulation factor XIIIA (F13A1): Novel perspectives in treatment and pharmacogenetics 273
Effect of factor XIII-A G185T polymorphism on visual prognosis after photodynamic therapy for neovascular macular degeneration 272
Methylenetetrahydrofolate reductase C677T and A1298C gene variants in adult non-Hodgkin's lymphoma patients: association with toxicity and survival 272
The active metabolite of warfarin (3′-hydroxywarfarin) and correlation with INR, warfarin and drug weekly dosage in patients under oral anticoagulant therapy: A pharmacogenetics study 268
Serum iron and matrix metalloproteinase-9 variations in limbs affected by chronic venous disease and venous leg ulcers 265
Sudden sensorineural hearing loss and polymorphisms in iron homeostasis genes: new insights from a case-control study 264
COVID-19 and individual genetic susceptibility/receptivity: Role of ACE1/ACE2 genes, immunity, inflammation and coagulation. might the double x-chromosome in females be protective against SARS-COV-2 compared to the single x-chromosome in males? 263
Crosstalk between adipokines and paraoxonase 1: A new potential axis linking oxidative stress and inflammation 260
Realizzazione di un DNA-Array di varianti genetiche nelle lesioni croniche di origine vascolare 258
F13A1 gene variant (V34L) and residual circulating FXIIIA levels predict short-and long-term mortality in acute myocardial infarction after coronary angioplasty 256
Factor XIII V34L polymorphism modulates the risk of chronic venous leg ulcer progression and extension 255
Changes in adipose tissue distribution and association between uric acid and bone health during menopause transition 255
Factor XIII contrasts the effects of metalloproteinases in human dermal fibroblast cultured cells 255
A De Novo and Heterozygous Gene Deletion Causing a Variant of von Willebrand Disease 254
Hemochromatosis C282Y gene mutation increases the risk of venous leg ulceration 253
FOLATE GENE VARIANTS AFFECT METHOTREXATE-RELATED TOXICITY IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS 253
A novel mutation (Leu817Pro) causing type 2A von Willebrand disease 250
High throughput array technologies: Expanding applications from clinics to applied research 246
Tissue factor and coagulation factor VII levels during acute myocardial infarction: Association with genotype and adverse events 244
“Bridging the Gap” Everything that Could Have Been Avoided If We Had Applied Gender Medicine, Pharmacogenetics and Personalized Medicine in the Gender-Omics and Sex-Omics Era 244
Factor XIII-A dynamics in acute myocardial infarction: a novel prognostic biomarker? 244
Analisi dei multimeri del fattore von Willebrand mediante doppia immunoprecipitazione dopo elettroforesi su gel di agarosio. 241
A common mutation in the gene for coagulation factor XIII-A (Val34Leu): A risk factor for primary intracerebral hemorrhage is protective against atherothrombotic diseases 240
The carboxyl-terminal region is not essential for secreted and functional levels of coagulation factor X 237
Assessment of the interlaboratory variability and robustness of JAK2V617F mutation assays: A study involving a consortium of 19 Italian laboratories 237
Coexistence of antithrombin deficiency, factor V Leiden and hyperhomocysteinemia in a thrombotic family. 234
Fisiopatologia dell'Emostasi e della Coagulazione 233
Genetic predictors of response to photodynamic therapy 232
A "de novo" Gene Deletion and New RFLPs Detected by von Willebrand Factor cDNA. 231
Influence of gene polymorphisms in ulcer healing process after superficial venous surgery 230
Prognostic role of Factor XIII gene variants in nonhealing venous leg ulcers 230
A DE NOVO GENE ALTERATION CAUSING VON WILLEBRAND DISEASE 229
DNA-array of gene variants in venous leg ulcers: Detection of prognostic indicators 229
A deep vein thrombosis in an adolescent diabetic boy: A case report | [Descrizione di un caso di trombosi venosa profonda in un adolescente diabetico] 226
C677T/A1298C MTHFR Gene Mutations, Homocysteine, Folate Levels and MTHFR Activity, in Normal Subjects and Cases with Myocardial Infarction 224
Coexistence of factor V G1691A and factor II G20210A gene mutations in a thrombotic family is associated with recurrence and early onset of venous thrombosis 223
Asymptomatic carriership of factor V Leiden and genotypes of the fibrinogen gene cluster 222
A photometric assay for factor-XIII in chronic hepatopathies. 221
Common gene polymorphisms in the metabolic folate and methylation pathway and the risk of acute lymphoblastic leukemia and non-Hodgkin's lymphoma in adults 220
Effects of electromagnetic fields on proteoglycan metabolism of bovine articular cartilage explants 217
Effects of physical stimulation with electromagnetic field and insulin growth factor-I treatment on proteoglycan synthesis of bovine articular cartilage 216
MTHFR 677C→T polymorphism and risk of coronary heart disease: A meta-analysis 216
Functional variations modulating PRKCA expression and alternative splicing predispose to multiple sclerosis 215
Polymorphisms in the genes coding for iron binding and transporting proteins are Associated with Disability, Severity, and Early Progression in Multiple Sclerosis. 214
The factor V Glu1608Lys mutation is recurrent in familial thrombophilia 213
FXIII levels and genotypes in myocardial infarction: a potential novel prognostic biomarker? 213
Quantitive evaluation of dentin sialoprotein (DSP) using microbeads - A potential early marker of root resorption 212
Influence of Genetic Polymorphisms in Ulcer Healing Process after Superficial Venous Surgery 211
Custom CGH array profiling of copy number variations (CNVs) on chromosome 6p21.32 (HLA locus) in patients with venous malformations associated with multiple sclerosis 210
A modified functional Global test to measure protein C, protein S activities and the activated protein C-resistance phenotype. 210
Investigation of in vitro cytotoxicity of the redox state of ionic iron in neuroblastoma cells. 209
The carboxyl-terminal region is NOT essential for secreted and functional levels of coagulation factor X 209
GENETIC SUSCEPTIBILITY IN VENOUS LEG ULCER 206
Cis-segregation of c.1171c>t stop codon (p.r391*) in serpinc1 gene and c.1691g>a transition (p.r506q) in f5 gene and selected gwas multilocus approach in inherited thrombophilia 205
Acute Coronaric Syndroms and FVII polymorphisms: different effects in the same gene 204
Redox metals homeostasis in multiple sclerosis and amyotrophic lateral sclerosis: a review 203
Characterization of polymorphic markers in the von Willebrand factor gene and pseudogene 203
Nanoengineering Approaches to Design Advanced Dental Materials for Clinical Applications. 201
A photometric method for the dosage of factor XIII applied to the study of chronic hepatopathies. 200
TIME- AND DOSE-DEPENDENT EFFECTS OF CHRONIC WOUND FLUID ON HUMAN ADULT DERMAL FIBROBLASTS 200
Risk of venous thromboembolism associated with single and combined effects of Factor V Leiden, Prothrombin 20210A and Methylenetethraydrofolate reductase C677T: a meta-analysis involving over 11,000 cases and 21,000 controls 195
Factor XIIIA V34L and Factor XIIIB H95R Gene Polymorphisms: Effects on the Risk of Myocardial Infarction and on Survival. 194
C677T Substitution in the Methylenetetrahydrofolate Reductase Gene as a Risk Factor for Venous Thrombosis and Arterial Disease in Selected Patients. 194
Expression Profiles of the Internal Jugular and Saphenous Veins: Focus on Hemostasis Genes 192
Partial gene deletion in a family with factor X deficiency 191
Sudden sensorineural hearing loss and polymorphisms in iron homeostasis genes. 191
Expression profiles of the internal jugular and saphenous veins: Focus on hemostasis genes 190
circRNAs as Epigenetic Regulators of Integrity in Blood–Brain Barrier Architecture: Mechanisms and Therapeutic Strategies in Multiple Sclerosis 189
An Italian Family with a Novel Mutation Causing Type 2A von Willebrand Disease and with Reduced Levels of von Willebrand Factor not Linked with the von Willebrand Factor Gene. 189
The reduced sensitivity of the ProC (R) Global test in protein S deficient subjects reflects a reduction in the associated thrombotic risk 188
Genetics and epigenetics of one-carbon metabolism pathway in autism spectrum disorder: A sex-specific brain epigenome? 188
Folate: metabolism, biochemistry and role in disease processes. 187
Genetic association and altered gene expression of mir-155 in multiple sclerosis patients 187
A de novo antithrombin mutation found in a patient with deep vein thrombosis and vascular abnormalities 184
Different anticoagulant response to activated protein C (APC test) and to Agkistrodon Contortix venom (ACV test) in a family with FV-R506Q substitution 183
Meta-analysis of multiple sclerosis microarray data reveals dysregulation in RNA splicing regulatory genes 183
Dihydrofolate reductase (DHFR) 19-bp ins/del polymorphism and methylenetetrahydrofolate reductase (MTHFR) C677T in coronary heart disease patients: potential intracellular folate unbalancing. 182
Low folate levels and thermolabile methylenetetrahydrofolate reductase as primary determinant of mild hyperhomocystinemia in normal and thromboembolic subjects 180
Deletion of exons 26-34 (domain D3-A3) of von Willebrand-factor gene in the von Willebrand disease type-II. 178
Maternal Haplotypes in DHFR Promoter and MTHFR Gene in Tuning Childhood Acute Lymphoblastic Leukemia Onset-Latency: Genetic/Epigenetic Mother/Child Dyad Study (GEMCDS) 178
Rapid detection of a protein C gene mutation present in the asymptomatic and not in the thrombosis‐prone lineage 177
Tissue Factor and Coagulation Factor VII Levels during Acute Myocardial Infarction Contribute to Predict Mortality and re-infarction. 176
A modified functional global test to measure PC, PS activities and the APC-resistance phenotype 176
Molecular defects in CRM+ factor VII deficiencies: modelling of missense mutations in the catalytic domain of FVII 176
What is potentially the right factor XIII for venous leg ulcer treatment? 175
Common Gene Polymorphisms in the Metabolic Folate and Methylation Pathway and the Risk of Acute Lymphoblastic Leukemia and non-Hodgkin’s Lymphoma 175
Factor XIIIA-V34L and factor XIIIB-H95R gene variants: effects on survival in myocardial infarction patients. 175
Common Polymorphisms in the Metabolic Folate Pathway Decrease the Risk of Acute Lymphocytic Leukemia in Adults 175
Detection of new polymorphic markers in the factor V gene: Association with factor V levels in plasma 174
Common Polymorphisms in the Metabolic Folate Pathway Decrease the Risk of Acute Lymphocitic Leukemia in Adults 174
Totale 24.437
Categoria #
all - tutte 206.130
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 9.389
Totale 215.519


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.009 210 380 272 98 247 124 118 116 101 253 301 789
2022/20233.069 328 212 78 377 496 507 167 279 317 32 174 102
2023/20241.611 148 190 69 46 162 247 49 110 34 53 75 428
2024/20256.923 204 157 543 215 892 500 239 423 1.180 902 945 723
2025/202619.466 1.665 860 1.622 2.538 2.632 1.286 2.192 1.137 1.847 2.037 1.092 558
2026/2027583 583 0 0 0 0 0 0 0 0 0 0 0
Totale 49.926